Functional oesophago-gastric junction imaging

Radiological landmarks at the oesophago-gastric junction.

Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience

BACKGROUND Oesophageal cancer is a major clinical problem with a generally poor prognosis. As a result there has been interest in combining surgery with neoadjuvant chemotherapy to try and improve outcomes, although the current evidence for benefit is inconsistent. We aimed to compare, in a non-randomised study, the post-operative complication rate and short and long-term survival of patients w...

[Oesophago-gastric cancer and minimally invasive surgery].

Oesophago-gastric cancer is the fifth most common type of malignancy and the fourth most frequent cause of death in the United Kingdom, affecting 13 500 people every year. Numerous epidemiological studies have shown that its incidence, particularly at the oesophago-gastric junction, has increased in recent years. The prognosis for this type of cancer is poor, with 5-year survival rates being ap...

The oesophago-gastric sphincter after cardiomyotomy.

Surgical operations performed for the relief of achalasia of the cardia are liable to be followed by gastro-oesophageal reflux. Although this complication occurred much more frequently after earlier procedures such as cardioplasty or oesophago-gastric anastomosis than after Heller's cardiomyotomy (Barrett and Franklin, 1949; Ripley, Olsen, and Kirklin, 1952; Brewer, Barnes, and Redo, 1956), it ...

Neoadjuvant Treatment for Oesophago-Gastric Cancer

In the United Kingdom, oesophageal cancer ranks as the ninth most common cancer with a rising incidence of 13 per 100,000 head of population. Some two-thirds of all oesophageal lesions are adenocarcinomas, the rest are squamous cell carcinomas. The incidence of stomach cancer is similar but a decline has been registered over the past two decades. For both conditions the age at presentation is 6...